Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: February 2004 March 15, 2004
Spinal Arthritis Market Worthwhile As 'Add-On' To Existing Therapies March 15, 2004 By Randy Osborne Industry pundits have been chanting about "consolidation" for years, using each new buyout as a way of proving their forecast - which, let's face it, is pretty much a fail-safe prediction.Read More
RSS